Dr. Hönle Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Markus Arendt

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureno data
Board average tenure2.2yrs

Recent management updates

Recent updates

Dr. Hönle AG's (ETR:HNL) Revenues Are Not Doing Enough For Some Investors

Jan 18
Dr. Hönle AG's (ETR:HNL) Revenues Are Not Doing Enough For Some Investors

The Price Is Right For Dr. Hönle AG (ETR:HNL) Even After Diving 26%

Sep 26
The Price Is Right For Dr. Hönle AG (ETR:HNL) Even After Diving 26%

Why Investors Shouldn't Be Surprised By Dr. Hönle AG's (ETR:HNL) P/S

Aug 06
Why Investors Shouldn't Be Surprised By Dr. Hönle AG's (ETR:HNL) P/S

Is There An Opportunity With Dr. Hönle AG's (ETR:HNL) 50% Undervaluation?

Jul 02
Is There An Opportunity With Dr. Hönle AG's (ETR:HNL) 50% Undervaluation?

Dr. Hönle AG's (ETR:HNL) Popularity With Investors Is Clear

Feb 08
Dr. Hönle AG's (ETR:HNL) Popularity With Investors Is Clear

We Think Dr. Hönle (ETR:HNL) Has A Fair Chunk Of Debt

Oct 11
We Think Dr. Hönle (ETR:HNL) Has A Fair Chunk Of Debt

Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?

Aug 07
Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?

Is Dr. Hönle (ETR:HNL) A Risky Investment?

Jun 03
Is Dr. Hönle (ETR:HNL) A Risky Investment?

The Returns On Capital At Dr. Hönle (ETR:HNL) Don't Inspire Confidence

Nov 03
The Returns On Capital At Dr. Hönle (ETR:HNL) Don't Inspire Confidence

Dr. Hönle (ETR:HNL) Has No Shortage Of Debt

Sep 29
Dr. Hönle (ETR:HNL) Has No Shortage Of Debt

There Are Reasons To Feel Uneasy About Dr. Hönle's (ETR:HNL) Returns On Capital

Jul 06
There Are Reasons To Feel Uneasy About Dr. Hönle's (ETR:HNL) Returns On Capital

Capital Allocation Trends At Dr. Hönle (ETR:HNL) Aren't Ideal

Feb 20
Capital Allocation Trends At Dr. Hönle (ETR:HNL) Aren't Ideal

Dr. Hönle AG (ETR:HNL) Shares Could Be 37% Below Their Intrinsic Value Estimate

Jul 15
Dr. Hönle AG (ETR:HNL) Shares Could Be 37% Below Their Intrinsic Value Estimate

Is Dr. Hönle (ETR:HNL) A Risky Investment?

Jun 14
Is Dr. Hönle (ETR:HNL) A Risky Investment?

Is Dr. Hönle AG (ETR:HNL) Potentially Undervalued?

May 30
Is Dr. Hönle AG (ETR:HNL) Potentially Undervalued?

Dr. Hönle (ETR:HNL) Could Be Struggling To Allocate Capital

May 17
Dr. Hönle (ETR:HNL) Could Be Struggling To Allocate Capital

Calculating The Fair Value Of Dr. Hönle AG (ETR:HNL)

Mar 29
Calculating The Fair Value Of Dr. Hönle AG (ETR:HNL)

Do Investors Have Good Reason To Be Wary Of Dr. Hönle AG's (ETR:HNL) 1.0% Dividend Yield?

Mar 16
Do Investors Have Good Reason To Be Wary Of Dr. Hönle AG's (ETR:HNL) 1.0% Dividend Yield?

We Think Dr. Hönle (ETR:HNL) Is Taking Some Risk With Its Debt

Mar 03
We Think Dr. Hönle (ETR:HNL) Is Taking Some Risk With Its Debt

Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?

Feb 20
Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?

We Wouldn't Rely On Dr. Hönle's (ETR:HNL) Statutory Earnings As A Guide

Feb 08
We Wouldn't Rely On Dr. Hönle's (ETR:HNL) Statutory Earnings As A Guide

Did Business Growth Power Dr. Hönle's (ETR:HNL) Share Price Gain of 131%?

Jan 25
Did Business Growth Power Dr. Hönle's (ETR:HNL) Share Price Gain of 131%?

Should We Be Excited About The Trends Of Returns At Dr. Hönle (ETR:HNL)?

Jan 11
Should We Be Excited About The Trends Of Returns At Dr. Hönle (ETR:HNL)?

What Kind Of Investors Own Most Of Dr. Hönle AG (ETR:HNL)?

Dec 27
What Kind Of Investors Own Most Of Dr. Hönle AG (ETR:HNL)?

Dr. Hönle AG (ETR:HNL) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Dec 15
Dr. Hönle AG (ETR:HNL) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Is Dr. Hönle AG (ETR:HNL) An Attractive Dividend Stock?

Dec 03
Is Dr. Hönle AG (ETR:HNL) An Attractive Dividend Stock?

These 4 Measures Indicate That Dr. Hönle (ETR:HNL) Is Using Debt Extensively

Nov 22
These 4 Measures Indicate That Dr. Hönle (ETR:HNL) Is Using Debt Extensively

CEO

Markus Arendt

less than a year

Tenure

Dr. Markus Arendt is Managing Director and Chairman of the Management Board of Dr. Hönle AG from May 01, 2024 and serves as its Chief Executive Officer since 2024.


Board Members

NamePositionTenureCompensationOwnership
Franz Richter
Chairman of Supervisory Boardless than a year€379.40kno data
Bernhard Gimple
Independent Deputy Chairman of Supervisory Board9.8yrs€30.00kno data
Imke Libon
Independent Member of Supervisory Board3.7yrs€30.00kno data
Niklas Friedrichsen
Supervisory Board Memberless than a year€43.00kno data
Melanie Ott
Independent Member of Supervisory Boardno datano datano data

2.2yrs

Average Tenure

56yo

Average Age

Experienced Board: HNL's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/18 01:11
End of Day Share Price 2025/01/17 00:00
Earnings2024/06/30
Annual Earnings2023/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dr. Hönle AG is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tim WunderlichHauck Aufhäuser Investment Banking
Alina KohlerHauck Aufhäuser Investment Banking
Anish DixitVirtua Research Inc.